413. Intravenous and Tablet Formulation of Posaconazole in Antifungal Therapy and Prophylaxis: A Retrospective, Non-Interventional, Multicenter Analysis of Patients Treated in German Tertiary-Care Hospitals

BACKGROUND: Novel formulations (gastro-resistant tablet and intravenous solution) of posaconazole (POS) have been approved in prophylaxis and therapy of invasive fungal diseases (IFDs). The aim of this multicenter noninterventional study was to analyze treatment strategies and clinical effectiveness...

Descripción completa

Detalles Bibliográficos
Autores principales: Heimann, Sebastian M, Penack, Olaf, Heinz, Werner J, Rachow, Tobias, Egerer, Gerlinde, Kessel, Johanna, Löhnert, Annika, Vehreschild, Janne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255490/
http://dx.doi.org/10.1093/ofid/ofy210.424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255490/
http://dx.doi.org/10.1093/ofid/ofy210.424

Ejemplares similares